🇺🇸 FDA
Pipeline program

Telavancin

0017

Phase 3 small_molecule completed

Quick answer

Telavancin for Staphylococcal Skin Infection is a Phase 3 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).

Program details

Company
CUMBERLAND PHARMACEUTICALS INC
Indication
Staphylococcal Skin Infection
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials